Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Invested Capital: 2009-2025

Historic Invested Capital for Aytu Biopharma (AYTU) over the last 17 years, with Jun 2025 value amounting to $28.0 million.

  • Aytu Biopharma's Invested Capital rose 11.58% to $38.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.0 million, marking a year-over-year increase of 11.58%. This contributed to the annual value of $28.0 million for FY2025, which is 6.91% down from last year.
  • Aytu Biopharma's Invested Capital amounted to $28.0 million in FY2025, which was down 6.91% from $30.1 million recorded in FY2024.
  • In the past 5 years, Aytu Biopharma's Invested Capital ranged from a high of $153.8 million in FY2021 and a low of $28.0 million during FY2025.
  • Moreover, its 3-year median value for Invested Capital was $30.1 million (2024), whereas its average is $33.0 million.
  • Per our database at Business Quant, Aytu Biopharma's Invested Capital surged by 61.58% in 2021 and then plummeted by 61.45% in 2022.
  • Aytu Biopharma's Invested Capital (MRY) stood at $153.8 million in 2021, then plummeted by 61.45% to $59.3 million in 2022, then crashed by 31.00% to $40.9 million in 2023, then decreased by 26.41% to $30.1 million in 2024, then decreased by 6.91% to $28.0 million in 2025.
  • Its Invested Capital was $28.0 million in FY2025, compared to $30.1 million in FY2024 and $40.9 million in FY2023.